Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Scholar Rock scores its first FDA approval for SMA treatment
The treatment, which is set to “ship in the coming days” is projected to cost $310,000 annually.
Donavyn Coffey
Sep 14, 2026 10:37am
GSK to shutter flu vaccine manufacturing site
Sep 14, 2026 9:46am
Why Earlier Commercial Involvement Drives Smarter Strategy
Brought to you by
Acumetis
Increased deaths shadow Enhertu’s first-line lung cancer data
Sep 13, 2026 7:00pm
Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay
Brought to you by
Bayer
GSK prepares frontline FDA bid for lung cancer drug Jideytro
Sep 13, 2026 7:00pm
